Latest Breaking News On - First oral epothilone anti cancer - Page 1 : comparemela.com

The orphan drug designation is a result of positive findings from a phase 2 clinical trial which demonstrated a 100% clinical benefit rate in patients.

Biostar pharma utideloneBiostar pharmaLi tangSebastian kaulitzkiBiostar pharma incHanmi pharmaceuticalsKinex pharmaceuticalsBiostar pharmaceuticalsUtidelone capsulePatients with advanced solidOdonate therapeuticsBiostar pharma announces first patient enrolledFirst oral epothilone anti cancer